Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Kalyan V. G. Nadiminti"'
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-16 (2024)
Abstract The AML treatment landscape has significantly changed in recent years with the approval of targeted therapies in the front-line and relapsed/refractory settings, including inhibitors of FLT3 and IDH1/2 mutations. More importantly, approval o
Externí odkaz:
https://doaj.org/article/74caab5841684d1485c8690d3fc55416
